Drug Shortage Report for ZOMIG RAPIMELT
| Report ID | 270283 |
| Drug Identification Number | 02243045 |
| Brand name | ZOMIG RAPIMELT |
| Common or Proper name | ZOLMITRIPTAN |
| Company Name | XEDITON PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLMITRIPTAN |
| Strength(s) | 2.5MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL ORAL |
| Packaging size | Blister packs of 6 tablets |
| ATC code | N02CC |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-24 |
| Estimated end date | 2025-11-30 |
| Actual end date | 2025-11-10 |
| Shortage status | Resolved |
| Updated date | 2025-11-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2020 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 6X7 |
| Company contact information | george.gafrey@xediton.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-11-20 | French | Compare |
| v4 | 2025-11-20 | English | Compare |
| v3 | 2025-10-25 | English | Compare |
| v2 | 2025-10-24 | French | Compare |
| v1 | 2025-10-24 | English | Compare |
Showing 1 to 5 of 5